Literature DB >> 11740998

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach.

D R Gandara1, P N Lara, D H Lau, P Mack, P H Gumerlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11740998     DOI： 10.1016/s0169-5002(01)00368-3

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  4 in total

1.  Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.

Authors:  Takuya Araki; Kimihiro Shimizu; Katsunori Nakamura; Tomonori Nakamura; Yasumasa Mitani; Kyoko Obayashi; Yukiyoshi Fujita; Seiichi Kakegawa; Yohei Miyamae; Kyoichi Kaira; Takefumi Ishidao; Alexander Lezhava; Yoshihide Hayashizaki; Izumi Takeyoshi; Koujirou Yamamoto
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

2.  Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.

Authors:  Yohei Miyamae; Kimihiro Shimizu; Yasumasa Mitani; Takuya Araki; Yuki Kawai; Masaru Baba; Seiichi Kakegawa; Masayuki Sugano; Kyoichi Kaira; Alexander Lezhava; Yoshihide Hayashizaki; Koujirou Yamamoto; Izumi Takeyoshi
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

3.  Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003.

Authors:  Philip C Mack; Mary W Redman; Kari Chansky; Stephen K Williamson; Nichole C Farneth; Primo N Lara; Wilbur A Franklin; Quynh-Thu Le; John J Crowley; David R Gandara
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

4.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

Authors:  Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.